A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Recruiting · NCT07477457 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 2 | 2026-03-17 | NCT07477457 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | United States | 46 |
| Memorial Sloan Kettering at Bergen (Limited Protocol Activities) | Montvale | United States | 12 |
| Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) | Middletown | United States | 11 |
| Memorial Sloan Kettering at Nassau (Limited Protocol Activities) | Uniondale | United States | 13 |
| Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities) | Commack | United States | 6 |
| Memorial Sloan Kettering at Westchester (Limited Protocol Activities) | Harrison | United States | 12 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | New York | United States | 47 |